LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls
LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls
Read moreWed, 12th Mar 2014 07:07
LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls
Read moreLONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near
Read moreTOP NEWS: Hikma hikes Generics guidance as interim profit swells
Read moreLONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance
Read more(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance for its generics arm and reported a rise in first-half profit and revenue as it hailed a strong performance in both the generics and branded segments, and resilience in the injectables business.
Read moreUK earnings, trading statements calendar - next 7 days
Read moreIN BRIEF: Arecor ends first half of 2021 with solid cash position
Read moreBROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight
Read moreBROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart
Read more(Adds background to case, paragraphs 4-10)By Blake BrittainWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against gener...
Read moreWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals PLC and Dr. Reddy's La...
Read more(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.
Read moreBROKER RATINGS: Exane BNP downgrades three property companies
Read moreLONDON MARKET CLOSE: Stocks close out impressive April to end higher
Read moreTOP NEWS: Hikma Pharma confident after promising start to year
Read more